Myocarditis and pericarditis following COVID-19 vaccines - The Melbourne Vaccine Education Centre (MVEC)
SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study | The BMJ
Myocarditis and pericarditis following COVID-19 vaccines - The Melbourne Vaccine Education Centre (MVEC)
Myocarditis, pericarditis remains rare after COVID-19 booster
Myocarditis, pericarditis remains rare after COVID-19 booster
Comparative Risk of Myocarditis/Pericarditis Following Second Doses of BNT162b2 and mRNA-1273 Coronavirus Vaccines | Journal of the American College of Cardiology
Myocarditis following COVID‐19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC ...
Increased risk of myocarditis and pericarditis and reduced likelihood of severe clinical outcomes associated with COVID-19 vaccination: a cohort study in Lombardy, Italy | BMC Infectious Diseases | Full Text
Israel reports very few myocarditis cases among 12-15 year olds after booster | Reuters
Myocarditis Associated With COVID-19 Booster Vaccination | Circulation: Cardiovascular Imaging
Myocarditis With COVID-19 mRNA Vaccines | Circulation
Myocarditis, pericarditis incidence low across 10 million doses of mRNA COVID-19 vaccines
RACGP - Vaccine and infection myocarditis risks contrasted
Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data — United States, March 2020–January 2021 | MMWR
CDC Extends COVID-19 Boosters to Adolescents, but Myocarditis Is Top of Mind | tctmd.com
Myocarditis: A Rare Occurrence Following COVID-19 Vaccination | University of Utah Health
Study evaluates risk estimates of myocarditis and pericarditis from mRNA-1273 and BNT162b2 vaccines
Myocarditis With COVID-19 mRNA Vaccines | Circulation
Heart risks, data gaps fuel debate over COVID-19 boosters for young people | Science | AAAS
COVID-19 infection more likely than vaccines to cause rare cardiovascular complications — Nuffield Department of Primary Care Health Sciences, University of Oxford
Israel reports very few myocarditis cases after Pfizer boosters | Reuters
Myocarditis Reported as Rare Adverse Event from COVID-19 Vaccine
RACGP - TGA releases updated COVID booster safety data
